STU 3 Candidate

This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

H.?? Value Set http://hl7.org/fhir/ValueSet/hspc-Ordinal-Abnormal-Union

This is a value set defined at http://www.clinicaleleement.com .

Summary

Defining URL:http://hl7.org/fhir/ValueSet/hspc-Ordinal-Abnormal-Union
Name:Ordinal Assessment or Interpretation
Definition:HL7 V3:ObservationInterpretation OID: 2.16.840.1.113883.5.83 + SNOMED CT SNOMED CT concepts from the Degree findings (qualifier value)272520006, Presence findings (qualifier value)260411009, Absence findings (qualifier value)272519000
Committee:FHIR Infrastructure Work Group
OID:2.16.840.1.113883.4.642.2.677 (for OID based terminology systems)
Copyright:IHC
Source ResourceXML / JSON

This value set is not currently used

H.??.1 Content Logical Definition

This value set includes codes from the following code systems:

  • Include all codes defined in http://hl7.org/fhir/v3/ObservationInterpretation
  • Include codes from http://snomed.info/sct where concept is-a 272520006
  • Include codes from http://snomed.info/sct where concept is-a 260411009
  • Include codes from http://snomed.info/sct where concept is-a 272519000

 

H.??.2 Expansion

This expansion generated 31 Mar 2016

This value set contains 199 concepts

CodeSystemDisplayDefinition
CARhttp://hl7.org/fhir/v3/ObservationInterpretationCarrierThe patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder.
Carrierhttp://hl7.org/fhir/v3/ObservationInterpretationCarrierThe patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. Deprecation Comment: This code is currently the same string as the print name for this concept and is inconsistent with the conventions being used for the other codes in the coding system, as it is a full word with initial capitalization, rather than an all upper case mnemonic. The recommendation from OO is to deprecate the code "Carrier" and to add "CAR" as the new active code representation for this concept.
Bhttp://hl7.org/fhir/v3/ObservationInterpretationBetterThe current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure). [Note: This can be applied to quantitative or qualitative observations.]
Dhttp://hl7.org/fhir/v3/ObservationInterpretationSignificant change downThe current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).
Uhttp://hl7.org/fhir/v3/ObservationInterpretationSignificant change upThe current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).
Whttp://hl7.org/fhir/v3/ObservationInterpretationWorseThe current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure). [Note: This can be applied to quantitative or qualitative observations.]
<http://hl7.org/fhir/v3/ObservationInterpretationOff scale lowThe result is below the minimum detection limit (the test procedure or equipment is the limiting factor). Synonyms: Below analytical limit, low off scale.
>http://hl7.org/fhir/v3/ObservationInterpretationOff scale highThe result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor). Synonyms: Above analytical limit, high off scale.
AChttp://hl7.org/fhir/v3/ObservationInterpretationAnti-complementary substances presentA valid result cannot be obtained for the specified component / analyte due to the presence of anti-complementary substances in the sample.
IEhttp://hl7.org/fhir/v3/ObservationInterpretationInsufficient evidenceThere is insufficient evidence that the species in question is a good target for therapy with the drug. A categorical interpretation is not possible. [Note: A MIC with "IE" and/or a comment may be reported (without an accompanying S, I or R-categorization).]
QCFhttp://hl7.org/fhir/v3/ObservationInterpretationQuality control failureA result cannot be considered valid for the specified component / analyte or organism due to failure in the quality control testing component.
TOXhttp://hl7.org/fhir/v3/ObservationInterpretationCytotoxic substance presentA valid result cannot be obtained for the specified organism or cell line due to the presence of cytotoxic substances in the sample or culture.
Ahttp://hl7.org/fhir/v3/ObservationInterpretationAbnormalThe result or observation value is outside the reference range or expected norm (as defined for the respective test procedure). [Note: Typically applies to non-numeric results.]
AAhttp://hl7.org/fhir/v3/ObservationInterpretationCritical abnormalThe result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure). [Note: Typically applies to non-numeric results. Analogous to critical/panic limits for numeric results.]
HHhttp://hl7.org/fhir/v3/ObservationInterpretationCritical highThe result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Above upper panic limits.
LLhttp://hl7.org/fhir/v3/ObservationInterpretationCritical lowThe result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Below lower panic limits.
Hhttp://hl7.org/fhir/v3/ObservationInterpretationHighThe result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure). Synonym: Above high normal
H>http://hl7.org/fhir/v3/ObservationInterpretationSignificantly highA test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician.[Note: This level is situated between 'H' and 'HH'.] Deprecation Comment: The code 'H>' is being deprecated in order to align with the use of the code 'HU' for "Very high" in V2 Table 0078 "Interpretation Codes". [Note: The use of code 'H>' is non-preferred, as this code is deprecated and on track to be retired; use code 'HU' instead.
HUhttp://hl7.org/fhir/v3/ObservationInterpretationSignificantly highA test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician.
Lhttp://hl7.org/fhir/v3/ObservationInterpretationLowThe result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure). Synonym: Below low normal
L<http://hl7.org/fhir/v3/ObservationInterpretationSignificantly lowA test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician.[Note: This level is situated between 'L' and 'LL'.] Deprecation Comment: The code 'L<' is being deprecated in order to align with the use of the code 'LU' for "Very low" in V2 Table 0078 "Interpretation Codes". [Note: The use of code 'L<' is non-preferred, as this code is deprecated and on track to be retired; use code 'LU' instead.
LUhttp://hl7.org/fhir/v3/ObservationInterpretationSignificantly lowA test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician.
Nhttp://hl7.org/fhir/v3/ObservationInterpretationNormalThe result or observation value is within the reference range or expected norm (as defined for the respective test procedure). [Note: Applies to numeric or non-numeric results.]
Ihttp://hl7.org/fhir/v3/ObservationInterpretationIntermediateBacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 [Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.] [Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.] [Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.] [Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]
MShttp://hl7.org/fhir/v3/ObservationInterpretationmoderately susceptibleThe patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. Deprecation Comment: This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012).
NShttp://hl7.org/fhir/v3/ObservationInterpretationNon-susceptibleA category used for isolates for which only a susceptible interpretive criterion has been designated because of the absence or rare occurrence of resistant strains. Isolates that have MICs above or zone diameters below the value indicated for the susceptible breakpoint should be reported as non-susceptible. NOTE 1: An isolate that is interpreted as non-susceptible does not necessarily mean that the isolate has a resistance mechanism. It is possible that isolates with MICs above the susceptible breakpoint that lack resistance mechanisms may be encountered within the wild-type distribution subsequent to the time the susceptible-only breakpoint is set. NOTE 2: For strains yielding results in the "nonsusceptible" category, organism identification and antimicrobial susceptibility test results should be confirmed. Synonym: decreased susceptibility.
Rhttp://hl7.org/fhir/v3/ObservationInterpretationResistantBacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 [Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.] [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]
SYN-Rhttp://hl7.org/fhir/v3/ObservationInterpretationSynergy - resistantA category for isolates where the bacteria (e.g. enterococci) are not susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will not be effective. Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside. Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.
Shttp://hl7.org/fhir/v3/ObservationInterpretationSusceptibleBacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2 [Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.] [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]
SDDhttp://hl7.org/fhir/v3/ObservationInterpretationSusceptible-dose dependentA category that includes isolates with antimicrobial agent minimum inhibitory concentrations (MICs) that approach usually attainable blood and tissue levels and for which response rates may be lower than for susceptible isolates. Reference: CLSI document M44-A2 2009 "Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline - second edition" - page 2.
SYN-Shttp://hl7.org/fhir/v3/ObservationInterpretationSynergy - susceptibleA category for isolates where the bacteria (e.g. enterococci) are susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will be effective. Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside. Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.
VShttp://hl7.org/fhir/v3/ObservationInterpretationvery susceptibleThe patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. Deprecation Comment: This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012).
EXhttp://hl7.org/fhir/v3/ObservationInterpretationoutside thresholdThe observation/test result is interpreted as being outside the inclusion range for a particular protocol within which the result is being reported. Example: A positive result on a Hepatitis screening test. Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects. These concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal "030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes. Members of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held.
HXhttp://hl7.org/fhir/v3/ObservationInterpretationabove high thresholdThe observation/test result is interpreted as being outside the inclusion range for a particular protocol within which the result is being reported. Example: A positive result on a Hepatitis screening test. Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects. These concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal "030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes. Members of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held.
LXhttp://hl7.org/fhir/v3/ObservationInterpretationbelow low thresholdThe numeric observation/test result is interpreted as being below the low threshold value for a particular protocol within which the result is being reported. Example: A Total White Blood Cell Count falling below a protocol-defined threshold value of 3000/mm^3 Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects. These concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal "030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes. Members of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held.
INDhttp://hl7.org/fhir/v3/ObservationInterpretationIndeterminateThe specified component / analyte, organism or clinical sign could neither be declared positive / negative nor detected / not detected by the performed test or procedure. Usage Note: For example, if the specimen was degraded, poorly processed, or was missing the required anatomic structures, then "indeterminate" (i.e. "cannot be determined") is the appropriate response, not "equivocal".
Ehttp://hl7.org/fhir/v3/ObservationInterpretationEquivocalThe test or procedure was successfully performed, but the results are borderline and can neither be declared positive / negative nor detected / not detected according to the current established criteria.
NEGhttp://hl7.org/fhir/v3/ObservationInterpretationNegativeAn absence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure. [Note: Negative does not necessarily imply the complete absence of the specified item.]
NDhttp://hl7.org/fhir/v3/ObservationInterpretationNot detectedThe presence of the specified component / analyte, organism or clinical sign could not be determined within the limit of detection of the performed test or procedure.
POShttp://hl7.org/fhir/v3/ObservationInterpretationPositiveA presence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure.
DEThttp://hl7.org/fhir/v3/ObservationInterpretationDetectedThe measurement of the specified component / analyte, organism or clinical sign above the limit of detection of the performed test or procedure.
EXPhttp://hl7.org/fhir/v3/ObservationInterpretationExpectedThis result has been evaluated in light of known contraindicators. Once those contraindicators have been taken into account the result is determined to be "Expected" (e.g., presence of drugs in a patient that is taking prescription medication for pain management).
UNEhttp://hl7.org/fhir/v3/ObservationInterpretationUnexpectedThis result has been evaluated in light of known contraindicators. Once those contraindicators have been taken into account the result is determined to be "Unexpected" (e.g., presence of non-prescribed drugs in a patient that is taking prescription medication for pain management).
NRhttp://hl7.org/fhir/v3/ObservationInterpretationNon-reactiveAn absence finding used to indicate that the specified component / analyte did not react measurably with the reagent.
RRhttp://hl7.org/fhir/v3/ObservationInterpretationReactiveA presence finding used to indicate that the specified component / analyte reacted with the reagent above the reliably measurable limit of the performed test.
WRhttp://hl7.org/fhir/v3/ObservationInterpretationWeakly reactiveA weighted presence finding used to indicate that the specified component / analyte reacted with the reagent, but below the reliably measurable limit of the performed test.
1250004http://snomed.info/sctDecreased
18043004http://snomed.info/sctThin
18307000http://snomed.info/sctAltered
20572008http://snomed.info/sctGood
30714006http://snomed.info/sctResistant
35105006http://snomed.info/sctIncreased
41277001http://snomed.info/sctLacking
42425007http://snomed.info/sctEquivocal
54328002http://snomed.info/sctIndifferent (qualifier value)
62482003http://snomed.info/sctLow
71978007http://snomed.info/sctInadequate
75540009http://snomed.info/sctHigh
82334004http://snomed.info/sctIndeterminate
84496004http://snomed.info/sctMicroscopic
88323005http://snomed.info/sctAdequate
131196009http://snomed.info/sctSusceptible
134223000http://snomed.info/sctNarrow
255358001http://snomed.info/sctRapid
255359009http://snomed.info/sctReducible
255361000http://snomed.info/sctSlow
255507004http://snomed.info/sctSmall
255509001http://snomed.info/sctLarge
255510006http://snomed.info/sctSlight
255511005http://snomed.info/sctLong
255587001http://snomed.info/sctPeak
255588006http://snomed.info/sctTrough
257390007http://snomed.info/sctStatic
258262008http://snomed.info/sctVery large
260352001http://snomed.info/sctMarginate
260354000http://snomed.info/sctModerate number
260355004http://snomed.info/sctModerate peak
260356003http://snomed.info/sctModerately resistant
260357007http://snomed.info/sctModerately susceptible
260358002http://snomed.info/sctVery
260359005http://snomed.info/sctVery heavy
260360000http://snomed.info/sctVery high
260361001http://snomed.info/sctVery light
260362008http://snomed.info/sctVery low
260364009http://snomed.info/sctAdditive
260365005http://snomed.info/sctHeightened
260366006http://snomed.info/sctIncrease
260369004http://snomed.info/sctIncreasing
260370003http://snomed.info/sctDecrease
260371004http://snomed.info/sctDecreasing
260372006http://snomed.info/sctDeficient
260375008http://snomed.info/sctEfficient
260376009http://snomed.info/sctEnlarged
260377000http://snomed.info/sctExaggerated
260378005http://snomed.info/sctExcessive
260379002http://snomed.info/sctImpaired
260380004http://snomed.info/sctInconsistent
260381000http://snomed.info/sctInefficient
260382007http://snomed.info/sctLarge peak
260383002http://snomed.info/sctLate
260384008http://snomed.info/sctLong duration
260394003http://snomed.info/sctNormal limits
260395002http://snomed.info/sctNormal range
260396001http://snomed.info/sctNumerous
260398000http://snomed.info/sctOveraction (+)
260399008http://snomed.info/sctRaised
260400001http://snomed.info/sctReduced
260401002http://snomed.info/sctSemi-formed
260402009http://snomed.info/sctShort duration
260403004http://snomed.info/sctSmall peak
260404005http://snomed.info/sctStrong
260405006http://snomed.info/sctTrace
260406007http://snomed.info/sctUnderaction (-)
260407003http://snomed.info/sctWeak
260409000http://snomed.info/sctWell defined
263656005http://snomed.info/sctAccurate
263745000http://snomed.info/sctEfficient emptying
263776006http://snomed.info/sctHeavy growth
263782009http://snomed.info/sctInaccurate
263812008http://snomed.info/sctModerate growth
263865001http://snomed.info/sctScanty
263866000http://snomed.info/sctScanty growth
263920009http://snomed.info/sctUnrecordable
263926003http://snomed.info/sctVery slow
264535005http://snomed.info/sctInefficient emptying
264841006http://snomed.info/sctIntermediately susceptible
300841009http://snomed.info/sctPoorly defined
359530003http://snomed.info/sctShortened
367450005http://snomed.info/sctShort
371879000http://snomed.info/sctAbnormally high (qualifier value)
371880002http://snomed.info/sctAbnormally low (qualifier value)
371925005http://snomed.info/sctMost significant (qualifier value)
371926006http://snomed.info/sctHighly significant (qualifier value)
371927002http://snomed.info/sctModerately significant (qualifier value)
371928007http://snomed.info/sctNot significant (qualifier value)
371929004http://snomed.info/sctMinimally significant (qualifier value)
385440003http://snomed.info/sctLowered (qualifier value)
386134007http://snomed.info/sctSignificant (qualifier value)
386135008http://snomed.info/sctSignificance undetermined (qualifier value)
419984006http://snomed.info/sctInconclusive (qualifier value)
423437008http://snomed.info/sctInsufficient (qualifier value)
425404009http://snomed.info/sctSlightly (qualifier value)
425405005http://snomed.info/sctExcellent (qualifier value)
428247006http://snomed.info/sctBlunted (qualifier value)
428691001http://snomed.info/sctAccentuated (qualifier value)
444871000124104http://snomed.info/sctVery good (qualifier value)
445451000124105http://snomed.info/sctModerately good (qualifier value)
445511000124105http://snomed.info/sctFair (qualifier value)
10828004http://snomed.info/sctPositive
43261007http://snomed.info/sctAbnormal presence of
46651001http://snomed.info/sctIsolated
52101004http://snomed.info/sctPresent (qualifier value)
83185005http://snomed.info/sctSensitive
260347006http://snomed.info/sctPresent + out of ++++ (qualifier value)
260348001http://snomed.info/sctPresent ++ out of ++++ (qualifier value)
260349009http://snomed.info/sctPresent +++ out of ++++ (qualifier value)
260350009http://snomed.info/sctPresent ++++ out of ++++ (qualifier value)
260351008http://snomed.info/sctJust noticeable
260373001http://snomed.info/sctDetected
260408008http://snomed.info/sctWeakly positive
260410005http://snomed.info/sctVital
260412002http://snomed.info/sctAnaerobes detected
260417008http://snomed.info/sctStrains different
260418003http://snomed.info/sctStrains similar
260976002http://snomed.info/sctPresence of infection
263650004http://snomed.info/sctPresence of calculi
263651000http://snomed.info/sctPresence of delta phalanx
264840007http://snomed.info/sctHyperplasia present
264866005http://snomed.info/sctNeoplasm present
264872005http://snomed.info/sctNodules present
373066001http://snomed.info/sctYes (qualifier value)
441517005http://snomed.info/sctPresent two plus out of three plus
441521003http://snomed.info/sctPresent three plus out of three plus
441614007http://snomed.info/sctPresent one plus out of three plus
2667000http://snomed.info/sctAbsent
17511009http://snomed.info/sctNormal absence
47492008http://snomed.info/sctNot seen (qualifier value)
260353006http://snomed.info/sctNothing at all
260385009http://snomed.info/sctNegative
260386005http://snomed.info/sctNil
260387001http://snomed.info/sctNo anaerobes detected
260389003http://snomed.info/sctNo reaction
260390007http://snomed.info/sctNon-vital
260391006http://snomed.info/sctNoninflammatory
260392004http://snomed.info/sctNon-patent
260393009http://snomed.info/sctNon-pigmented
260413007http://snomed.info/sctNone
260414001http://snomed.info/sctNothing
260415000http://snomed.info/sctNot detected
260416004http://snomed.info/sctNot itching
264868006http://snomed.info/sctNo growth
264869003http://snomed.info/sctNo neoplasm
264871003http://snomed.info/sctNodules absent
264887000http://snomed.info/sctNot isolated
264915001http://snomed.info/sctReceptor absent
264929000http://snomed.info/sctSuperadded infection absent
276727009http://snomed.info/sctNull
373067005http://snomed.info/sctNo (qualifier value)
444991000124106http://snomed.info/sctRepeatedly non-reactive (qualifier value)

This value set includes codes from the following code systems:

     

    See the full registry of value sets defined as part of FHIR.

    Explanation of the columns that may appear on this page:

    LevelA few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
    SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
    CodeThe code (used as the code in the resource instance)
    DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
    DefinitionAn explanation of the meaning of the concept
    CommentsAdditional notes about how to use the code